# Remix Therapeutics, Inc. — Form D

Remix Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-04. The offering totals $90.0M, of which $13.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-01-04
- Form: D
- Accession: 0002006953-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $90.0M
- Amount sold: $13.7M
- Remaining: $76.3M
- Investors: 21
- Date of first sale: 2023-12-22
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-501562

## Issuer

- Name: Remix Therapeutics, Inc.
- CIK: 0002006953
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 100 FORGE ROAD, WATERTOWN, MA, 02472
- Phone: 781-827-0901

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Scott Biller | Director | Watertown, MA |
| Kevin Bitterman | Director | Cambridge, MA |
| Jeff Goater | Director | New York, NY |
| Matthew Patterson | Director | South San Francisco, CA |
| Michael Rome | Director | Palm Beach, FL |
| Peter Smith | Director | Branchburg, NJ |
| Robert Gagnon | Executive Officer | Rehovot, L3 |
| Peter Smith | Executive Officer | Branchburg, NJ |
| Heather Wasserman | Executive Officer | Watertown, MA |

## More

- [CIK 2006953 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2006953&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002006953-24-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.